Function of the hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain

Journal of Rheumatology

Volumn 25, Issue 7, 1998, Pages 1374-1381

  Griep, Eduard N ^a,b,g   Boersma, Johannes W ^c   Lentjes, Eef G W M ^d   A Prins, A Pieter ^a   Van Der Korst, Jan K ^e   De Kloet, E Ronald ^f  

^a JAN VAN BREEMEN INSTITUTE   (Netherlands)

^b Medical Center   (Netherlands)

^c RIJNSTATE HOSPITAL   (Netherlands)

^d Department of Clinical Chemistry

^e Department of Rheumatology ^*  (Netherlands)

^f LEIDEN UNIVERSITY   (Netherlands)

^g MEDICAL CENTER LEEUWARDEN   (Netherlands)

Author keywords

ACTH; Cortisol; Fibromyalgia; Low back pain; Neuroendocrinology; Stress

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; GLUCOCORTICOID; HYDROCORTISONE; TETRACOSACTIDE;

ADULT; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN RELEASE; CORTICOTROPIN TEST; DEXAMETHASONE SUPPRESSION TEST; FEEDBACK SYSTEM; FEMALE; FIBROMYALGIA; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOGLYCEMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTRAVENOUS DRUG ADMINISTRATION; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STRESS;

ADOLESCENT; ADRENOCORTICOTROPIC HORMONE; ADULT; CORTICOTROPIN-RELEASING HORMONE; DEXAMETHASONE; FEMALE; FIBROMYALGIA; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LOW BACK PAIN; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM;

EID: 0031835646     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Yunus MB, Masi AT, Calabro JJ, Miller KA, Feigenbaum SL. Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum 1981;11:151-71.
2. Campbell SM, Clark S, Tindall EA, Forehand ME, Bennett RM. Clinical characteristics of fibrositis. I. A "blinded," controlled study of symptoms and tender points. Arthritis Rheum 1983;26:817-24.
3. Wolfe F. Fibromyalgia. Rheum Dis Clin North Am 1990;16:681-98.
4. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 1990;33:160-72.
5. Moldofsky H, Scarisbrick P, England R, Smythe H. Musculoskeletal symptoms and non-REM sleep disturbance in patients with "fibrositis syndrome" and healthy subjects. Psychosom Med 1975;37:341-51.
6. Moldofsky H. Rheumatic pain modulation syndrome; the interrelationship between sleep, central nervous system serotonin and pain. In: Critchley M, Friedman A, Forini S, Sicuteri F, editors. Advances in neurology. New York: Raven Press; 1982:51-7.
7. Uveges JM, Parker JC, Smarr KL, et al. Psychological symptoms in primary fibromyalgia syndrome: relationship to pain, life stress and sleep disturbance. Arthritis Rheum 1990;33:1279-83.
8. Dailey PA, Bishop GD, Russell IJ, Fletcher EM. Psychological stress and the fibrositis/fibromyalgia syndrome. J Rheumatol 1990;17:1380-5.
9. Yunus MB. Psychological aspects of fibromyalgia syndrome: a component of the dysfunctional spectrum syndrome. Bailliere's Clin Rheumatol 1994;8:811-37.
10. Bennett RM. Fibromyalgia and the facts: sense or nonsense. Rheum Dis Clin North Am 1993;19:45-59.
11. Block SR. Fibromyalgia and the rheumatisms: common sense and sensibility. Rheum Dis Clin North Am 1993;19:61-78.
12. Cohen ML, Quintner JL. Fibromyalgia syndrome, a problem of tautology. Lancet 1993;342:906-9.
13. Goldenberg DL. Fibromyalgia, why such controversy? Ann Rheum Dis 1995;54:3-5.
14. Goldenberg DL. Fibromyalgia, chronic fatigue syndrome and myofascial pain syndrome. Curr Opin Rheumatol 1995;7:127-35.
15. 133Xenon clearance from exercising muscle. Arthritis Rheum 1989;32:454-60.
16. Russell IJ. Neurohormonal aspects of fibromyalgia syndrome. Rheum Dis Clin North Am 1989;15:149-68.
17. Yunus MB. Towards a model of pathophysiology of fibromyalgia: aberrant central pain mechanisms with peripheral modulation [editorial]. J Rheumatol 1992;19:846-50.
18. McCain GA, Tilbe KS. Diurnal hormone variation in fibromyalgia syndrome: a comparison with rheumatoid arthritis. J Rheumatol 1989;16 Suppl 19:154-7.
19. Ferraccioli G, Cavalieri F, Salaffi F, et al. Neuroendocrinologic findings in primary fibromyalgia and in other chronic rheumatic conditions [editorial]. J Rheumatol 1990;17:869-73.
20. Griep EN, Boersma JW, De Kloet ER. Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. J Rheumatol 1993;20:469-74.
21. Bohus B, Benus RF, Fokkema DS, et al. Neuroendocrine states and behavioral and physiological stress responses. Prog Brain Res 1987;72:57-70.
22. Holsboer F. Psychiatric implications of altered limbic-hypothalamic-pituitary-adrenocortical activity. Eur Arch Psychiatr Neurol Sci 1989;238:302-22.
23. Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 1992;267:1244-52.
24. Griep EN, Boersma JW, De Kloet ER. Evidence for neuroendocrine disturbance following physical exercise in primary fibromyalgia syndrome. J Musculoskel Pain 1993;1:217-22.
25. Griep EN, Boersma JW, De Kloet ER. Pituitary release of growth hormone and prolactin in the primary fibromyalgia syndrome. J Rheumatol 1994;21:2125-30.
26. Bennett RM, Clark SR, Campbell SM, Burckhardt CS. Low levels of somatomedin C in patients with the fibromyalgia syndrome. Arthritis Rheum 1992;35:1113-6.
27. Sternberg EM. Hypo(er)immune fatigue syndromes: diseases of the stress response? [editorial]. J Rheumatol 1993;20:418-21.
28. Vaerøy H, Helle R, Førre Ø, Kåss E, Terenius L. Elevated CSF levels of substance P and high incidence of Raynaud's phenomenon in patients with fibromyalgia: new features for diagnosis. Pain 1988;32:21-6.
29. Russell IJ, Orr MD, Littman B, et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 1994;37:1593-601.
30. Frymoyer JW. Back pain and sciatica. N Engl J Med 1988;318:291-300.
31. Crauford DIO, Creed F, Jayson MIV. Life events and psychological disturbance in patients with low-back pain. Spine 1990;15:490-4.
32. Tyrrell JB, Forsham PH. Glucocorticoids and adrenal androgens. In: Greenspan FS, Forsham PH, editors. Basic and clinical endocrinology. Los Altos: Lange; 1986;272-309.
33. Hermus AR, Pieters GF, Pesman GJ, Smals AG, Benraad ThJ, Kloppenborg PW. The corticotropin-releasing hormone test versus the high-dose dexamethasone test in the differential diagnosis of Cushing's syndrome. Lancet 1986;2:540-3.
34. Lentjes EGWM, Romijn F, Maassen RJ, De Graaf L, Gautier P, Moolenaar AJ. A temperature controlled plasma free cortisol assay using the Amicon MPS-1 ultrafiltration apparatus and the Abbott TDx. Clin Chem 1993;39:2518-21.
35. Winer BJ, Brown DR, Michels KM. Statistical principles in experimental design. New York: McGraw-Hill; 1991.
36. Siegel S, Castellan NJ Jr. Nonparametric statistics for the behavioral sciences. New York: McGraw-Hill; 1989.
37. Crofford LJ, Pillemer SR, Kalogeras KT, et al. Hypothalamicpituitary-adrenal axis pertubations in patients with fibromyalgia. Arthritis Rheum 1994;37:1583-92.
38. Neeck G, Riedel W. Thyroid function in patients with fibromyalgia syndrome. J Rheumatol 1992;19:1120-2.
39. Vinson GP, Hinson JP, Toth IE. The neuroendocrinology of the adrenal cortex. J Neuroendocrinology 1994;6:235-46.
40. 1 antagonist. J Neuroscience 1996;16:5555-65.
41. Van Denderen JC, Boersma JW, Zeinstra P, Hollander AP, Van Neerbos BR. Physiological effects of exhaustive physical exercise in primary fibromyalgia syndrome (PFS): is PFS a disorder of neuroendocrine reactivity? Scand J Rheumatol 1992;21:35-7.
42. Lápossy E, Maleitzke R, Hrycaj P, Mennet W, Müller W. The frequency of transition of chronic low back pain to fibromyalgia. Scand J Rheumatol 1995;24:29-33.
43. Holsboer F, Lauer CJ, Schreiber WJ, et al. Altered hypothalamic-pituitary-adrenocortical regulation in healthy individuals at high familial risk for depression. Neuroendocrinology 1995;62:340-7.
44. Disdier P, Harle J-R, Brue T, et al. Severe fibromyalgia after hypophysectomy for Cushing's disease. Arthritis Rheum 1991;34:493-5.
45. Harvey AR. A neurogenic model for soft-tissue rheumatism and its implications for management: concept. J Orthop Rheumatol 1990;3:231-42.
46. Russell IJ, Vaerøy H, Javors M, Nyberg F. Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 1992;35:550-6.
47. Mountz JM, Bradley LA, Modell JG, et al. Fibromyalgia in women: abnormalities of regional cerebral blood flow in the thalamus and the caudate nuclei are associated with low pain thresholds levels. Arthritis Rheum 1995;38:926-38.
48. Hudson JI, Pope HG. The concepts of affective spectrum disorder: relationship to fibromyalgia and other syndromes of chronic fatigue and chronic muscle pain. Baillieres Clin Rheumatol 1994;8:839-56.
49. Raadsheer FC. Increased activity of hypothalamic corticotropin-releasing neurons in aging, Alzheimer's disease and depression [thesis]. Amsterdam: University of Amsterdam; 1994.
50. Demitrack MA, Dale JK, Straus SE, et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 1991;73:1224-34.
51. Yehuda R, Southwick J, Krystal JH, Eharney DS, Maron JW. Enhanced suppression of cortisol following low dose of dexamethasone in combat veterans with post-traumatic stress disorder. Am J Psychiatr 1993;150:83-96.